Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide begins working from the first dose, but most people notice meaningful appetite changes somewhere between two and eight weeks in — with significant weight reduction typically building over months rather than days. It is a prescription-only medicine, so a prescriber assesses whether it suits your situation before treatment begins. Here is what the clinical evidence and NHS guidance on semaglutide actually tell us about the timeline.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the most common situation people describe. The first pen is set at 0.25 mg, a dose chosen entirely for tolerability, not for its immediate effect on the scale. Your body is adjusting to a new signal in your gut-hormone pathway; the nausea and appetite changes that tell you something is happening often take a fortnight to show up clearly. Some people feel a subtle difference after a few days, food becomes slightly less compelling, portions feel like enough sooner. Others notice nothing at all until the dose steps up.
That absence of drama in week one is not a sign the medicine is failing. The STEP 1 trial, which ran for 68 weeks and tested semaglutide 2.4 mg against placebo, recorded an average weight reduction of around 15%, but that figure accumulated across the full trial period, not the first few weeks. The early weeks are groundwork. Staying consistent with the schedule your prescriber set, eating regular protein-rich meals, and keeping hydrated is genuinely useful at this stage, even when the numbers on the scale have not shifted.
If you are curious about how the medicine works on a biological level, our overview of semaglutide's mechanism walks through the GLP-1 pathway in plain terms.
By the time the dose increases to 0.5 mg or beyond, the majority of people on semaglutide report a clear shift in appetite. Cravings quiet down. Meals that used to feel inadequate become satisfying. For some, this is the first time in years that food has not occupied the background of every afternoon. That effect is real, pharmacological, and consistent with the trial data.
Weight loss during this window is typically modest in absolute terms, perhaps one to three kilograms depending on starting weight, diet, and activity. That pace is healthy. Rapid early loss often reflects fluid shifts rather than fat reduction, and it rarely holds. Steady loss across months is both safer and more durable. If you want a clearer picture of how long Wegovy typically takes to work at each stage of the dosing schedule, our dedicated guide breaks it down week by week.
The timing of your weekly injection can also influence how you feel day to day. Choosing a consistent day and time helps maintain even levels in the bloodstream and makes the routine easier to stick with, a practical detail that sounds small but makes a difference over the long haul.
Side effects, if they appear, tend to peak in these middle weeks as doses increase. Nausea, loose stools, or indigestion are the most common. They usually ease within a week or two of each step-up. Slowing down meals, avoiding very fatty food, and eating smaller portions helps considerably.
The STEP 1 trial's headline result (approximately 15% average weight loss at 68 weeks) tells you something important: the medicine keeps working well past the point where many people assume they should have seen everything it can do. Weight loss often plateaus temporarily, then resumes. Some people hit a flat patch at three or four months and conclude the medicine has stopped working; in most cases, it has not.
The escalation schedule matters here. Semaglutide moves through 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg, and up to 2.4 mg, with roughly four weeks at each level. That means a person does not reach the full maintenance dose until around month four or five of treatment. Results naturally accelerate once the therapeutic dose is established.
NICE's appraisal of semaglutide for weight management notes that if less than 5% of body weight has been lost after six months on the maintenance dose, the prescriber should review whether treatment remains appropriate. That threshold is a clinical checkpoint, not a verdict on whether the medicine works, individual responses vary considerably, and factors like diet, sleep, stress levels, and other medicines all influence the outcome.
For a closer look at how Wegovy fits into a longer-term plan, our Wegovy treatment page covers eligibility, the licensed dosing pathway, and what to expect throughout treatment.
A handful of things genuinely do affect how quickly semaglutide produces results. Inconsistent dosing is the biggest: skipping a week, or taking injections at very irregular intervals, disrupts the steady-state concentration the medicine needs to work properly. A question our prescribers hear regularly is whether supplements or herbal products interact with treatment, interactions with things like moringa are worth understanding before adding anything new to your routine.
Diet quality matters too, but not in the way people sometimes assume. The medicine reduces appetite; it does not neutralise the effect of a consistently poor diet. Pairing it with regular meals, adequate protein, and some movement gives it the best conditions to show what it can do.
Semaglutide is a prescription-only medicine, and the prescriber who approved your treatment is the right person to contact if progress has genuinely stalled after giving it a full and consistent run. You can also explore the broader semaglutide treatment information on this site, or check our frequently asked questions for practical answers to common queries. If you have not yet started treatment, a free consultation with our prescribers is a sensible first step, no waiting list, and you get a real clinical decision, not a template response.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.